A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II)
著者
吉野 茂文
掲載雑誌名
BMC Cancer
学部・研究科名
医学部
抄録
URL
本サイトへの掲載日
2012-11-19
Copyright(C) Yamaguchi University Library. All rights reserved
